-
Varian to acquire Cancer Treatment Services International for $283M
biospectrumasia
May 21, 2019
This transaction will accelerate identification of unmet clinical and operational needs to facilitate advances in technology and services.
-
Thermo Fisher to acquire GSK API Site for €90 M
biospectrumasia
May 20, 2019
Expands global footprint for complex API manufacturing
-
Boston Scientific to acquire Vertfilex for $465M
biospectrumasia
May 13, 2019
Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies
-
Novartis to acquire Xiidra in a $5.3B deal
biospectrumasia
May 12, 2019
Xiidra is the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease
-
M3 acquires majority share in DailyRounds
biospectrumasia
April 23, 2019
M3, Inc. of Japan announced acquisition of a majority stake of India based Neuroglia Health Private Limited (NHPL), a le……
-
Boehringer Ingelheim acquires ICD Therapeutics
biospectrumasia
April 02, 2019
Boehringer Ingelheim has announced that it has acquired ICD Therapeutics.
-
Stryker acquires OrthoSpace in a $110M deal
biospectrumasia
March 15, 2019
InSpace is a biodegradable sub-acromial spacer, which is designed to realign the natural biomechanics of the shoulder.
-
Fujifilm to acquire Biogen in a $890 M deal
biospectrumasia
March 13, 2019
FUJIFILM Corporation ("Fujifilm") announced that it has entered into an agreement to acquire Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark ("Biogen Hillerød") from Biogen for ap
-
Accenture to acquire Enterprise System Partners
biospectrumasia
March 06, 2019
Accenture has agreed to acquire Enterprise System Partners (ESP), a consulting and manufacturing services provider for the life sciences industry that is headquartered in Cork, Ireland, serving clients around the globe.
-
Sagent Pharma acquires Raleigh manufacturing site
biospectrumasia
March 05, 2019
The manufacturing site, which is approved for manufacturing of both small molecule and biologic products, is the first FDA-approved facility in the Nichi-Iko Group network.